Keros Therapeutics, Inc.(KROS)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KROS Keros Therapeutics, Inc.

休市中 05-03 16:00:00 EDT

60.57

+3.47

+6.08%

盘后60.57

+0.000.00%

16:26 EDT

最高62.19	最低57.32	成交量57.21万
今开57.32	昨收57.10	日振幅8.53%
总市值21.85亿	流通市值18.76亿	总股本3,607万
成交额3,446万	换手率1.85%	流通股本3,097万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"KROS","market":"US","secType":"STK","nameCN":"Keros Therapeutics, Inc.","latestPrice":60.57,"timestamp":1714766400000,"preClose":57.1,"halted":0,"volume":572094,"hourTrading":{"tag":"盘后","latestPrice":60.57,"preClose":60.57,"latestTime":"16:26 EDT","volume":7006,"amount":424362.19,"timestamp":1714767969614},"delay":0,"floatShares":30968183,"shares":36067786,"eps":-5.195482,"marketStatus":"休市中","marketStatusCode":7,"change":3.47,"latestTime":"05-03 16:00:00 EDT","open":57.32,"high":62.19,"low":57.32,"amount":34456975.61958,"amplitude":0.085289,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.195482,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714982400000},"adr":0,"listingDate":1586318400000,"adjPreClose":57.1,"preHourTrading":{"tag":"盘前","latestPrice":57.57,"preClose":57.1,"latestTime":"09:28 EDT","volume":100,"amount":5757,"timestamp":1714742880092},"postHourTrading":{"tag":"盘后","latestPrice":60.57,"preClose":60.57,"latestTime":"16:26 EDT","volume":7006,"amount":424362.19,"timestamp":1714767969614},"volumeRatio":1.8825210322371588},"requestUrl":"/m/hq/s/KROS/tweets","defaultTab":"tweets","newsList":[{"id":"2431505341","title":"Keros Therapeutics Inc    预计每股亏损 1.35 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2431505341","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2431505341?lang=zh_cn&edition=full","pubTime":"2024-04-30 20:22","pubTimestamp":1714479772,"startTime":"0","endTime":"0","summary":"   * Keros Therapeutics Inc    将于5月2日公布截至2024年3月31日的财报() 预计该公司的季度收入将保持不变。*    * LSEG 的分析师平均预计 Keros Therapeutics Inc 每股亏损 1.35 美元。* 过去三个月，分析师的平均盈利预期下降了约 0.5%。* 华尔街对 Keros Therapeutics Inc 的 12 个月目标价中值为 85.50 美元，高于其上一次收盘价 58.62 美元。4月30日 - 上一季度业绩。除非另有说明，所有数字均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2430233265","title":"Keros Therapeutics, Inc.盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430233265","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430233265?lang=zh_cn&edition=full","pubTime":"2024-04-25 23:45","pubTimestamp":1714059918,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日23时45分，Keros Therapeutics, Inc.股票出现异动，股价大幅下跌5.00%。Keros Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.77%。Keros Therapeutics, Inc.公司简介：Keros Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化新的治疗方法，用于医疗需求未得到满足的患有血液病、肺病和心血管疾病的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240425234518861e925f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240425234518861e925f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427752357","title":"Keros Therapeutics, Inc.盘中异动 下午盘大幅下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427752357","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427752357?lang=zh_cn&edition=full","pubTime":"2024-04-13 03:07","pubTimestamp":1712948835,"startTime":"0","endTime":"0","summary":"北京时间2024年04月13日03时07分，Keros Therapeutics, Inc.股票出现波动，股价大幅下跌5.00%。Keros Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.64%。Keros Therapeutics, Inc.公司简介：Keros Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为患有血液病、肺病和心血管疾病且医疗需求未得到满足的患者发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240413030716792040b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240413030716792040b9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426655444","title":"Keros Therapeutics, Inc.盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426655444","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426655444?lang=zh_cn&edition=full","pubTime":"2024-04-11 02:41","pubTimestamp":1712774512,"startTime":"0","endTime":"0","summary":"北京时间2024年04月11日02时41分，Keros Therapeutics, Inc.股票出现异动，股价急速跳水5.01%。Keros Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.08%。Keros Therapeutics, Inc.公司简介：Keros Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为患有血液病、肺病和心血管疾病且医疗需求未得到满足的患者发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240411024153861e4b92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240411024153861e4b92&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424404942","title":"Keros Therapeutics, Inc.盘中异动 早盘股价大跌5.00%报63.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424404942","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424404942?lang=zh_cn&edition=full","pubTime":"2024-04-02 22:02","pubTimestamp":1712066543,"startTime":"0","endTime":"0","summary":"北京时间2024年04月02日22时02分，Keros Therapeutics, Inc.股票出现波动，股价大幅跳水5.00%。Keros Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.62%。Keros Therapeutics, Inc.公司简介：Keros Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为患有血液病、肺病和心血管疾病且医疗需求未得到满足的患者发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240402220223861e303e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240402220223861e303e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421411819","title":"Keros Therapeutics, Inc.盘中异动 股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421411819","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421411819?lang=zh_cn&edition=full","pubTime":"2024-03-22 21:30","pubTimestamp":1711114235,"startTime":"0","endTime":"0","summary":"北京时间2024年03月22日21时30分，Keros Therapeutics, Inc.股票出现波动，股价快速跳水5.13%。Keros Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。Keros Therapeutics, Inc.公司简介：Keros Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为患有血液病、肺病和心血管疾病且医疗需求未得到满足的患者发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240322213036791c4e2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240322213036791c4e2b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419900202","title":"Keros Therapeutics, Inc.盘中异动 股价大涨5.35%报68.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419900202","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419900202?lang=zh_cn&edition=full","pubTime":"2024-03-16 01:18","pubTimestamp":1710523098,"startTime":"0","endTime":"0","summary":"北京时间2024年03月16日01时18分，Keros Therapeutics, Inc.股票出现异动，股价快速拉升5.35%。Keros Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。Keros Therapeutics, Inc.公司简介：Keros Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为患有血液病、肺病和心血管疾病且医疗需求未得到满足的患者发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240316011819861deb9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240316011819861deb9e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417057412","title":"Keros Therapeutics, Inc.盘中异动 股价大跌5.19%报65.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417057412","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417057412?lang=zh_cn&edition=full","pubTime":"2024-03-05 22:32","pubTimestamp":1709649160,"startTime":"0","endTime":"0","summary":"北京时间2024年03月05日22时32分，Keros Therapeutics, Inc.股票出现波动，股价快速跳水5.19%。截至发稿，该股报65.43美元/股，成交量1.3772万股，换手率0.04%，振幅2.71%。Keros Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。Keros Therapeutics, Inc.公司简介：Keros Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为患有血液病、肺病和心血管疾病且医疗需求未得到满足的患者发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030522324087546727&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030522324087546727&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417126288","title":"Keros Therapeutics, Inc.2023财年实现净利润-1.53亿美元，同比减少45.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417126288","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417126288?lang=zh_cn&edition=full","pubTime":"2024-03-05 00:26","pubTimestamp":1709569587,"startTime":"0","endTime":"0","summary":"12月31日，Keros Therapeutics, Inc.公布财报，公告显示公司2023财年净利润为-1.53亿美元，同比减少45.71%；其中营业收入为151000.00美元，每股基本收益为-5.20美元。从资产负债表来看，Keros Therapeutics, Inc.总负债37.81百万美元，其中短期债务1.01百万美元，资产负债比为0.10，流动比率为0.15。机构评级：截至2023年12月31日，当前有10家机构对Keros Therapeutics, Inc.目标价做出预测，其中目标均价为85.20美元，其中最低目标价为60.00美元，最高目标价为105.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403050026308b02cda0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403050026308b02cda0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416737629","title":"Keros Therapeutics, Inc.盘中异动 快速上涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416737629","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416737629?lang=zh_cn&edition=full","pubTime":"2024-03-02 01:20","pubTimestamp":1709313620,"startTime":"0","endTime":"0","summary":"北京时间2024年03月02日01时20分，Keros Therapeutics, Inc.股票出现异动，股价快速上涨5.16%。Keros Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.68%。Keros Therapeutics, Inc.公司简介：Keros Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为患有血液病、肺病和心血管疾病且医疗需求未得到满足的患者发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240302012020861da9c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240302012020861da9c3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2415526724","title":"Keros Therapeutics, Inc.盘中异动 早盘大幅拉升6.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2415526724","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2415526724?lang=zh_cn&edition=full","pubTime":"2024-02-29 22:34","pubTimestamp":1709217242,"startTime":"0","endTime":"0","summary":"北京时间2024年02月29日22时34分，Keros Therapeutics, Inc.股票出现异动，股价大幅上涨6.40%。Keros Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。Keros Therapeutics, Inc.公司简介：Keros Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为患有血液病、肺病和心血管疾病且医疗需求未得到满足的患者发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022922340287d240ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022922340287d240ab&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414349610","title":"Keros Therapeutics Inc    预计每股亏损 1.37 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2414349610","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2414349610?lang=zh_cn&edition=full","pubTime":"2024-02-28 19:02","pubTimestamp":1709118138,"startTime":"0","endTime":"0","summary":"   * Keros Therapeutics Inc    预计在3月1日发布业绩报告时，季度营收将保持不变。*    * LSEG 的分析师平均预计 Keros Therapeutics Inc 每股亏损 1.37 美元。* 华尔街对 Keros Therapeutics Inc 的 12 个月目标价中位数为 85.00 美元，高于其上次收盘价 70.00 美元。2月28日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2414180702","title":"Keros Therapeutics Inc盘中异动 股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2414180702","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414180702?lang=zh_cn&edition=full","pubTime":"2024-02-28 00:43","pubTimestamp":1709052191,"startTime":"0","endTime":"0","summary":"北京时间2024年02月28日00时43分，Keros Therapeutics Inc股票出现异动，股价快速拉升5.05%。Keros Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.17%。Keros Therapeutics Inc公司简介：Keros Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为患有血液病、肺病和心血管疾病且医疗需求未得到满足的患者发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022800431187e73a67&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022800431187e73a67&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414834149","title":"Keros Therapeutics Inc盘中异动 股价大涨5.01%报66.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2414834149","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414834149?lang=zh_cn&edition=full","pubTime":"2024-02-27 00:25","pubTimestamp":1708964702,"startTime":"0","endTime":"0","summary":"北京时间2024年02月27日00时25分，Keros Therapeutics Inc股票出现波动，股价大幅拉升5.01%。截至发稿，该股报66.80美元/股，成交量9.4575万股，换手率0.28%，振幅5.32%。Keros Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.08%。Keros Therapeutics Inc公司简介：Keros Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为患有血液病、肺病和心血管疾病且医疗需求未得到满足的患者发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240227002502861d86f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240227002502861d86f6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413968327","title":"Keros Therapeutics Inc盘中异动 急速拉升5.10%报64.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2413968327","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413968327?lang=zh_cn&edition=full","pubTime":"2024-02-24 00:34","pubTimestamp":1708706083,"startTime":"0","endTime":"0","summary":"北京时间2024年02月24日00时34分，Keros Therapeutics Inc股票出现波动，股价急速拉升5.10%。截至发稿，该股报64.10美元/股，成交量6.3695万股，换手率0.19%，振幅6.43%。Keros Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.39%。Keros Therapeutics Inc公司简介：Keros Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为患有血液病、肺病和心血管疾病且医疗需求未得到满足的患者发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402240034447a462a04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402240034447a462a04&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411501663","title":"Keros Therapeutics Inc盘中异动 早盘急速跳水5.02%报54.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2411501663","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2411501663?lang=zh_cn&edition=full","pubTime":"2024-02-13 22:31","pubTimestamp":1707834690,"startTime":"0","endTime":"0","summary":"北京时间2024年02月13日22时31分，Keros Therapeutics Inc股票出现异动，股价急速下跌5.02%。Keros Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.66%。Keros Therapeutics Inc公司简介：Keros Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为患有血液病、肺病和心血管疾病且医疗需求未得到满足的患者发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021322313079113ba1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021322313079113ba1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2409748328","title":"Keros Therapeutics Inc盘中异动 股价大涨10.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2409748328","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2409748328?lang=zh_cn&edition=full","pubTime":"2024-02-08 22:30","pubTimestamp":1707402634,"startTime":"0","endTime":"0","summary":"北京时间2024年02月08日22时30分，Keros Therapeutics Inc股票出现波动，股价急速上涨10.27%。Keros Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.14%。Keros Therapeutics Inc公司简介：Keros Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为患有血液病、肺病和心血管疾病且医疗需求未得到满足的患者发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240208223034861d4b7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240208223034861d4b7a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2408933673","title":"Keros Therapeutics Inc盘中异动 早盘急速跳水5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2408933673","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2408933673?lang=zh_cn&edition=full","pubTime":"2024-02-02 23:37","pubTimestamp":1706888231,"startTime":"0","endTime":"0","summary":"北京时间2024年02月02日23时37分，Keros Therapeutics Inc股票出现波动，股价快速下跌5.02%。Keros Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.68%。Keros Therapeutics Inc公司简介：Keros Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为患有血液病、肺病和心血管疾病且医疗需求未得到满足的患者发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240202233711790ea58c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240202233711790ea58c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2404535472","title":"Keros Therapeutics Inc盘中异动 早盘股价大跌8.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2404535472","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2404535472?lang=zh_cn&edition=full","pubTime":"2024-01-17 22:30","pubTimestamp":1705501844,"startTime":"0","endTime":"0","summary":"北京时间2024年01月17日22时30分，Keros Therapeutics Inc股票出现波动，股价急速跳水8.20%。Keros Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.00%。Keros Therapeutics Inc公司简介：Keros Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为患有血液病、肺病和心血管疾病且医疗需求未得到满足的患者发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401172230447a3bf8ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401172230447a3bf8ad&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2402846995","title":"Keros Therapeutics Inc盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2402846995","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2402846995?lang=zh_cn&edition=full","pubTime":"2024-01-09 02:49","pubTimestamp":1704739793,"startTime":"0","endTime":"0","summary":"北京时间2024年01月09日02时49分，Keros Therapeutics Inc股票出现波动，股价急速上涨5.02%。Keros Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.34%。Keros Therapeutics Inc公司简介：Keros Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为患有血液病、肺病和心血管疾病且医疗需求未得到满足的患者发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240109024954861c9367&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240109024954861c9367&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kerostx.com","stockEarnings":[{"period":"1week","weight":0.0468},{"period":"1month","weight":-0.0533},{"period":"3month","weight":0.1424},{"period":"6month","weight":0.8964},{"period":"1year","weight":0.3306},{"period":"ytd","weight":0.5234}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":-0.0156},{"period":"3month","weight":0.0343},{"period":"6month","weight":0.1762},{"period":"1year","weight":0.262},{"period":"ytd","weight":0.0757}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Keros Therapeutics, Inc.最初于2015年12月根据特拉华州法律注册成立。该公司是一家临床阶段生物制药公司，专注于为血液学和肌肉骨骼疾病患者开发和商业化新型治疗方法。该公司在了解转化生长因子β（一种蛋白质家族）的作用方面处于领先地位，它是红细胞和血小板生产以及肌肉和骨骼生长、修复和维护的主要调节者。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.053332},{"month":2,"riseRate":0.75,"avgChangeRate":0.108403},{"month":3,"riseRate":0.25,"avgChangeRate":-0.066035},{"month":4,"riseRate":0.25,"avgChangeRate":-0.044825},{"month":5,"riseRate":0.4,"avgChangeRate":-0.061751},{"month":6,"riseRate":0.25,"avgChangeRate":-0.064863},{"month":7,"riseRate":0.5,"avgChangeRate":-0.018592},{"month":8,"riseRate":0.5,"avgChangeRate":0.130737},{"month":9,"riseRate":0.5,"avgChangeRate":-0.033002},{"month":10,"riseRate":0.75,"avgChangeRate":0.182372},{"month":11,"riseRate":0.75,"avgChangeRate":0.187569},{"month":12,"riseRate":0.5,"avgChangeRate":0.063916}],"exchange":"NASDAQ","name":"Keros Therapeutics, Inc.","nameEN":"Keros Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Keros Therapeutics, Inc.(KROS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Keros Therapeutics, Inc.(KROS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Keros Therapeutics, Inc.,KROS,Keros Therapeutics, Inc.股票,Keros Therapeutics, Inc.股票老虎,Keros Therapeutics, Inc.股票老虎国际,Keros Therapeutics, Inc.行情,Keros Therapeutics, Inc.股票行情,Keros Therapeutics, Inc.股价,Keros Therapeutics, Inc.股市,Keros Therapeutics, Inc.股票价格,Keros Therapeutics, Inc.股票交易,Keros Therapeutics, Inc.股票购买,Keros Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Keros Therapeutics, Inc.(KROS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Keros Therapeutics, Inc.(KROS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况